{"product_id":"new-rapid-acting-antidepressants-contemporary-clinical-neuroscience","title":"New Rapid-acting Antidepressants (Contemporary Clinical Neuroscience)","description":"\u003cp\u003eBy Kenji Hashimoto, Mario Manto ​This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2\/3 antagonists and AMPA receptor agonists.  There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy.  The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area.  In this volume, a variety of novel pharmaceutical treatments are examined.  This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments. Product Details Publisher ‏ : ‎ Springer; 1st ed. 2021 edition (October 23, 2021) Language ‏ : ‎ English Hardcover ‏ : ‎ 156 pages ISBN-10 ‏ : ‎ 3030797899 ISBN-13 ‏ : ‎ 978-3030797898 ISBN-13 ‏ : ‎ 9783030797898 eText ISBN: 9783030797904\u003c\/p\u003e","brand":"Internal Medicine","offers":[{"title":"Default Title","offer_id":48959674220718,"sku":null,"price":27.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0765\/8179\/8062\/files\/9783030797898.jpg?v=1787958206","url":"https:\/\/ebooksmedical.com\/products\/new-rapid-acting-antidepressants-contemporary-clinical-neuroscience","provider":"Ebooks Medical","version":"1.0","type":"link"}